7,956 followers
Approval @FDAOncology of PD1 in BCG refractory #bladdercancer is import for clinical care tho cost is factor https://t.co/X0G9dMihIn Some pts don't benefit & more #immunotherapy research needed! @BladderCancerUS @BladderCancerUK https://t.co/8iJnAg2iQ